Introgen cuts 29% of jobs as it moves to market cancer therapy Jul 8, 2008
Advexin p53 is designed to treat recurrent head and neck cancer. By harnessing the body's natural tumor-suppression mechanisms, the treatment fights cancer without some of the toxicities associated with conventional cancer treatments. (Austin Business Journal, TX)
Introgen stock rises as company seeks FDA approval of cancer drug Jul 1, 2008
Advexin p53 is designed to treat recurrent head and neck cancer ... "With the use of p53 biomarkers, Advexin will provide more effective and less toxic treatment for head and neck cancer patients who have limited treatment options.". (Austin Business Journal, TX)
GlaxoSmithKline, Exelixis to end 6-year collaboration Jun 28, 2008
The compound, now called GSK089, is in Phase II trials for papillary renal cell carcinoma, gastric cancer and head and neck cancer. GSK can pick an additional compound among six programs: XL184, which will start Phase III trials this summer for glioblastoma, medullary thyroid cancer and non-small cell lung cancer; XL820, in Phase II for gastrointestinal stromal tumor; XL281, in Phase I for patients with advanced solid tumors; XL228, in Phase I for chronic myelogenous leukemia, Philadelphia... (San Francisco Business Journal)
Caphosol favorably impacts both the rate and severity of oral mucositis in cancer patients Jun 28, 2008
The most common malignancies among the participants were breast cancer (31 percent), head and neck cancer (31 percent) and colorectal cancer (11 percent) ... The use of Caphosol also had a favorable impact on the severity of OM: Mild OM (Grade 0/1) was found in more than 90 percent of chemotherapy patients and 40 percent of head and neck cancer patients ... Severe OM (Grade 3/4) was found in only 1-2 percent of chemotherapy patients and 18 percent of head and neck cancer patients (with only one... (EurekAlert!)
Cancer center celebrates an anniversary Jun 25, 2008
"We have a whole generation of head and neck cancer patients who will never get surgery now because we have proved that combination therapy can be just as effective without the need for surgery," Foens said. "If those patients had to coordinate their treatments in Waterloo and Grundy Center or Mason City it would be very difficult for them to continue on with their daily activities. ... This kind of practice was revolutionary 20 years ago, but it is still meeting our patients' needs today.". (Waterloo-Cedar Falls Courier)
YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL Jun 20, 2008
It is approved in several countries for treatment of various types of head and neck cancer. This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. (PR Newswire)
An HIV-Positive Man with Cutaneous Merkel-Cell Carcinoma Jun 19, 2008
Dr. Gregory K. Robbins (Infectious Diseases): A 63-year-old man was referred to the clinic for head and neck cancer, a multidisciplinary unit of this hospital, for management of cutaneous Merkel-cell carcinoma. He had been well until 3 months earlier, when he noted a small, painless nodule on the superior, right-central aspect of his forehead. (New England Journal of Medicine)
Combining Radiation And Surgery Significantly Improves Survival For Head And Neck Cancer Patients Jun 15, 2008
14, 2008) Adding radiation therapy to surgery significantly improves overall survival in patients diagnosed with node-positive head and neck cancer when compared to treating with surgery alone, according to a study in the June issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology ... Radiation therapy is commonly used after surgery to treat some head and neck cancers, but very few studies have... (Science Daily)
Police chief battles cancer, speaks out against chew tobacco Jun 5, 2008
"I was still trying to recover from being cut head to toe when they sent me to chemo and radiation," said Hahn, 33, who was diagnosed with head and neck cancer in April 2007 ... Four days later Hahn was diagnosed with head and neck cancer and scheduled for emergency surgery at the Huntsman Cancer Institute at the University of Utah in Salt Lake City. (Casper Star-Tribune, WY)
Drugs show success in the treatment of several cancers Jun 3, 2008
Patients with locally advanced head and neck cancer may respond better to treatment when the drug cetuximab is added to standard chemotherapy, according to findings presented by University of Pittsburgh researchers yesterday in Chicago at the annual meeting of the American Society of Clinical Oncology. Out of 37 patients, 32 responded to initial therapy with that treatment regimen, and all patients had full or partial reduction of their tumors later after radiation treatment, said Dr. Ethan... (Pittsburgh Post Gazette)
Anemia Drugs May Speed Tumor Growth in Some Cancer Patients Jun 3, 2008
They also voted to recommend against the drugs' use in patients with breast or head and neck cancer ... The results of the current study were based on analyses of tumor samples from 101 patients diagnosed with head and neck cancer who had participated in a previous phase III trial of erythropoietin. (MEDLINEplus)
Acupuncture Eases Side Effects of Head, Neck Cancer Treatments Jun 3, 2008
SUNDAY, June 1 (HealthDay News) -- Two of the more common and unpleasant side effects of treatment for head and neck cancer patients may be relieved by the ancient Chinese practice of acupuncture ... Neck dissection, or removal of the lymph nodes and surrounding tissue, is common in treating head and neck cancers. (MEDLINEplus)
Study is seen as boost for ImClone Jun 2, 2008
It is also approved to treat head and neck cancer. But data presented here could change that. (Boston Globe)
UPDATE:Colon Cancer Study Backs Gene's Role In Erbitux Benefit Jun 2, 2008
It is already approved to treat head and neck cancer, as well as colorectal cancer that has failed previous therapy. The response rate in the Erbitux arm was 59% in wild-type patients, compared to 43% in chemotherapy alone. (CNNMoney.com)
Easing The Pain After Cancer Surgery Jun 2, 2008
Acupuncture eases pain in head and neck cancer surgery Posted: 02 June 2008 1510 hrs. Photos. (Channelnewsasia.com)
Cancer drug developed by Introgen founder meets with clinical success Jun 1, 2008
Advexin, a modified adenovirus that uses the tumor-suppressing gene p53, is being used for end-stage head and neck cancer. Introgen co-founder and M.D. Anderson Professor Jack Roth invented the drug. (Austin Business Journal, TX)
Acupuncture reduces pain and dysfunction in head and neck cancer patients after neck dissection Jun 1, 2008
New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection ... Neck dissection is a common procedure for treatment of head and neck cancer. (EurekAlert!)
Gene Therapy Increases Survival For End-stage Head And Neck Cancer May 30, 2008
Introgen Therapeutics, Inc., reported results of its phase III trial of Advexin(r), a modified adenovirus that expresses the tumor-suppressing gene p53, for end-stage head and neck cancer ... The trial showed that p53 expression in the patient's tumor before treatment is a reliable biomarker for how to treat head and neck cancer ... Introgen developed a commercial-grade version of the drug and advanced it through phase II and III clinical trials for head and neck cancer. (Science Daily)
Quality of life predicts cancer survival, U-M study finds May 30, 2008
Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center ... The researchers surveyed 495 people at four hospitals who had been diagnosed with head and neck cancer within the previous two years ... Based on their findings, the study authors recommend routine quality of life assessments of patients with head and neck cancer, before treatment and again... (EurekAlert!)
New Immunization Strategy Could Be Effective Against 10 To 15 Percent Of All Cancers May 28, 2008
20, 2007) Researchers have developed a vaccine strategy for head and neck cancer that targets multiple peptides to activate the immune system to attack tumors. Their findings on cancer vaccines will be. (Science Daily)
Fruit, Veggies May Lower Head and Neck Cancer Risk May 27, 2008
Smoking and heavy drinking are two major risk factors for head and neck cancers, but even when the researchers accounted for such lifestyle factors, fruits and vegetables remained linked to lower cancer risks ... Past studies have suggested that fruits and vegetables and the nutrients they contain -- including various antioxidant compounds -- might help protect against head and neck cancers ... For example, participants who ate the most vegetables -- typically between three and four servings a... (MEDLINEplus)
Antidepressant May Help Head/Neck Cancer Patients May 27, 2008
NEW YORK (Reuters Health) - The results of a pilot study suggest that antidepressant therapy with Celexa during treatment for head and neck cancer reduces the risk of depression and diminishes the impact of cancer treatment on quality of life. Depression has been reported in up to 40 percent of patients with head and neck cancer "typically within the first 3 months of diagnosis," Dr. William M. Lydiatt and colleagues write in the journal, Archives of Otolaryngology -- Head and Neck Surgery ...... (MEDLINEplus)
U of L researchers link HPV with head, neck cancers May 21, 2008
Cancer researchers at the 's James Graham Brown Cancer Center have found that the human papillomavirus (HPV) is present in about one-third of head and neck cancers studied. The research team, led by U of L resident Payal Desai, looked at tissue samples from 43 patients with head and neck cancer of unknown origin ... "These results indicate that current vaccines, which protect against the HPV 16 virus, could prevent a large number of head and neck cancer cases," the university said in the... (Louisville Business First, KY)
Young woman opts for double mastectomy, removal of ovaries to beat cancer threat May 18, 2008
It is unclear if the gene is linked to the head and neck cancer she had in 1988. Stoltz also plans to have a double mastectomy to reduce her risk of developing breast cancer a second time. (Montana Standard, MT)
CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients May 17, 2008
These data confirm that CAPHOSOL is a useful tool to help oncology nurses and other healthcare professionals in the management of OM and related symptoms, particularly in patients with head and neck cancer and those receiving chemotherapy ... The rate of severe oral mucositis (NCI Clinical OM Grade 3-4) reported by head and neck cancer patients using CAPHOSOL in this study was 11% (Grade 3) and 2% (Grade 4) ... Historically, the incidence of severe OM in head and neck cancer patients receiving... (EurekAlert!)
Imclones Erbitux BMS-099 trial not powered to show overall survival, FLEX remains pivotal registrational trial May 16, 2008
Erbitux is a monoclonal antibody currently approved to treat head and neck cancer and colon cancer. It is also being tested for use in non-small cell lung cancer (NSCLC), with key trial results expected at the upcoming American Society of Clinical Oncology conference in Chicago. (FT.com -- Markets)
HPV Linked To Better Survival In Tonsil, Tongue Cancer, Study Finds May 15, 2008
Cancers of the tonsils and the base of the tongue have increased in recent years, in what Carey calls an "epidemic" of HPV-induced head and neck cancer. This has occurred at the same time that declines in smoking rates have led to a decrease in the incidence of other types of head and neck cancers ... About 35,300 Americans will be diagnosed with head and neck cancer this year, according to the American Cancer Society. (Science Daily)
Does Brushing Teeth Fight Lung Cancer May 15, 2008
The rates went up 68 percent for head and neck cancer and 54 percent for lung cancer. The researchers also found that the more teeth someone lost, the greater the chance of cancer. (Click2Houston, TX)
High-Tech Imaging No Better for Diagnosing Head/Neck Cancers May 15, 2008
TUESDAY, May 13 (HealthDay News) -- An advanced imaging technique to detect head and neck cancer may not boost a patient's odds of receiving an early or more accurate diagnosis of the disease, new findings suggest ... The findings are based on an analysis of 32 previously published studies done on head and neck cancer patients with one or fewer nodal metastases. (MEDLINEplus)
Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin May 14, 2008
CALGARY, May 14 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a Phase II clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with advanced head and neck cancers ... "Interim data recently presented from... (PR Newswire)
Tooth loss strongly linked to risk of esophageal, head and neck, and lung cancer May 14, 2008
The researchers specifically found that people with tooth loss were 136 percent more likely to develop esophageal cancer, had a 68 percent increased risk of developing head and neck cancer and a 54 percent greater chance of developing lung cancer. The researchers also found that the rate of cancer increased proportionally to the number of teeth a patient had lost. (EurekAlert!)
NASCAR widow's warning May 7, 2008
35,000 new cases of oral, head and neck cancer expected in U.S. this year ... So what is she doing at an oral, head and neck cancer screening at an Atlanta, Georgia, hospital ... The American Cancer Society estimates 35,000 new cases of oral, head and neck cancer will be diagnosed in the United States this year, accounting for between 3 and 5 percent of all cancers. (CNN -- Health)
New Surgery Improves Head And Neck Cancer Treatment May 2, 2008
ScienceDaily (May 2, 2008) A new surgical procedure for head and neck cancer at the University of Alabama at Birmingham offers improved accuracy for surgeons and reduced post-operative pain for patients ... The new procedure uses robotic surgery, and results have shown it lessens the scarring, breathing problems and damage to speech that can happen with treating head and neck cancers, said William Carroll, M.D., a scientist in the UAB Comprehensive Cancer Center ... "This application takes... (Science Daily)
Possible Viral Links to Lung Cancer Risk Uncovered May 2, 2008
It has also recently been implicated as a possible cause for head and neck cancer. Further studies are planned to look for signs of HPV infection in the respiratory tract of lung cancer patients and to explore the possibility for using HPV infection as a screening indicator for the disease. (MEDLINEplus)
Health/Science calendar Apr 21, 2008
FRI., APRIL 25Free cancer screening Massachusetts Eye and Ear Infirmary will provide free head and neck cancer screening. From 9 a.m. to 3 p.m., Massachusetts Eye and Ear Infirmary, 11th floor, 243 Charles St. For reservations call 617-573-4084. (Boston Globe)
HEALTH BRIEFS Apr 16, 2008
head, neck cancers The Oregon Health & Science University Cancer Institute will host a free head and neck cancer screening and awareness day ... Head and neck cancers affect the scalp, face, nose, mouth, throat, thyroid and neck. (OregonLive, OR -- News)
It's Neck-and-neck Down The Long Stretch For 2 Stroke-prevention Procedures Apr 15, 2008
22, 2007) Giving patients with head and neck cancer a combination of chemotherapy and radiation therapy controls the cancer and allows many patients to avoid additional surgery to the neck, according to a ... (May 16, 2007) Cigarette smoking is more strongly associated with head and neck cancers than drinking alcohol, according to a new study. (Science Daily)
DNA Paternity Test Almost Fooled: Man Put Someone Else's Saliva In His Mouth Apr 13, 2008
5, 2008) A morning gargle could someday be more than a breath freshener -- it could spot head and neck cancer, say scientists. Their new study of a mouth rinse that captures genetic signatures common to the. (Science Daily)
YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT AACR ANNUAL MEETING Apr 12, 2008
" About YM BioSciences YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company has two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is approved in several countries for treatment of various types of head and neck cancer; and AeroLEF(TM), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl... (PR Newswire)
Cancer Stem Cells Created With New Technique Apr 12, 2008
Clarke has since moved to Stanford, where he is the Karel H. and Avice N. Beekhuis Professor in Cancer Biology, and Stanford has become a leader in cancer stem cell research, with teams finding cancer stem cells in head and neck cancer, colorectal cancer and additional blood cancers. Laboratory researchers at the medical school are also beginning to work with clinical groups to apply cancer stem cell findings to patient care. (Science Daily)
Former racer headed back to Daytona Apr 12, 2008
Bobby Hamilton Racing is urging fans to take part in the Oral, Head and Neck Cancer Awareness Week from April 21 to 27. More than 150 medical centers across the nation will hold free screenings. (Yahoo News -- Auto Racing)
Ear, Nose, And Throat Specialist Joins FCMC Apr 11, 2008
He completed his residency at P.C.O.M., with specialty training at Buffalo General Hospital, New York, in head and neck cancer surgery and Shadyside Hospital, Pittsburgh, Pa. in advanced sinus surgery and facial nerve surgery. (Fulton County News, PA)
Mayo Clinic identifies treatment target for liver cancer recurrence and survival Apr 11, 2008
In 2007, Dr. Lai presented information at the annual meeting of the American Association for Cancer Research on the role of SULF2 in survival of patients with head and neck cancer -- the first concrete link to survival of patients with a specific tumor type. . (EurekAlert!)
Double binding sites on tumor target may provide future combination therapy Apr 9, 2008
Three years ago, Kate Ferguson, PhD, Assistant Professor of Physiology, and colleagues determined the precise molecular details of how Erbitux, a colorectal and head and neck cancer drug, binds to its target on cancer cells. EGFR drugs halt cell proliferation by blocking EGFRs molecular doorway, keeping hormones from binding and signaling tumor growth. (EurekAlert!)
HPV, Periodontitis Work In Tandem To Increase Risk Of Tongue Cancer Apr 7, 2008
Studies conducted elsewhere have found that HPV is an independent risk factor for a subset of head and neck cancers ... If these results are confirmed by other studies, this has a tremendous relevance in predicting and intervening in the initiation and prognosis of HPV-related diseases, including head and neck cancers ... " The study involved 30 patients newly diagnosed with squamous cell carcinoma on the base of the tongue between 1999 and 2005 at Roswell Park Cancer Institute for whom data was... (Science Daily)
'Liquor + fag = Cancer' Apr 7, 2008
Delivering a keynote address on the concluding day of the International Conference on Head and Neck Cancer organised under the aegis of Mahavir Cancer Sansthan (MCS) here, Dr Hosal said the government must come forward to check the growing menace of cancer in India ... The new building would be constructed on the MCS campus at a cost of Rs 8 crore to provide better medical facilities to head and neck cancer patients, he said adding about 42 per cent of the cancer patients in Bihar were suffering... (India Times, India -- Health/Science)
Inhibition of Chemokine Receptor Activation May Improve Head and Neck Cancer Therapies, Study Suggests Mar 27, 2008
5 percent reduction in viability after treatment with a targeted therapy, called erlotinib, that is already being used in squamous cell head and neck cancer treatment ... (May 16, 2007) Cigarette smoking is more strongly associated with head and neck cancers than drinking alcohol, according to a new study. (Science Daily)
Ontario ordered to pay woman's U.S. medical bills Mar 27, 2008
The cancer treatment offered "fell short of appropriate care for someone in her circumstances," according to the letter from Dr. Ensley, who specializes in head and neck cancer at Barbara Ann Karmanos Cancer Center. The treatment plan in Windsor might not have used the same chemotherapy drugs in the same high doses, in the same manner. (Globe and Mail)
Identical Genes from Parents May Raise Cancer Risk Mar 27, 2008
So, Eng and her colleagues decided to look at 400 genetic markers scattered throughout the genome in 385 breast, prostate and head and neck cancer patients and in people without cancer. All patients were of the same ethnic group. (MEDLINEplus)
Head and Neck Cancer Outcomes a Mixed Bag Mar 20, 2008
In background information in the study, the researchers noted that head and neck cancer treatment such as feeding tube placement, chemotherapy and radiation "tend to produce pain, disfigurement, eating problems and communication problems. Many patients become disabled, and about one-third of patients continue to smoke, and half are depressed.". This study by David L. Ronis, of the Veterans Affairs Ann Arbor Healthcare System and the University of Michigan School of Nursing, Ann Arbor, and... (MEDLINEplus)
Cause Of Severe Allergic Reaction To Cancer Drug Found Mar 17, 2008
16, 2008) Clinicians have been perplexed by the fact that some patients given the drug cetuximab--an immune-based therapy commonly used to treat persons diagnosed with head and neck cancer, or colon cancer--have a severe and rapid adverse reaction to the drug ... 19, 2007) Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to. (Science Daily)
Factors behind Head and Neck Cancer Revealed Mar 15, 2008
WASHINGTON (Reuters) - There are two distinct culprits behind head and neck cancer -- the long-recognized heavy tobacco and alcohol use as well as a common sexually transmitted virus, researchers said on Tuesday. The risk factors are so dramatically different in head and neck cancer in people infected with the human papillomavirus, or HPV, that it should be considered a separate disease from cases in which patients are not infected, researchers at Johns Hopkins University in Baltimore said ...... (MEDLINEplus)
All The Wrong Numbers Mar 15, 2008
Thursday, Amgen shares surged 5% as advisers told the Food and Drug Administration to warn patients not to use the company's top-selling anemia drug for head and neck cancer, breast cancer or in any case where patients might be cured of their cancer by chemotherapy. Investors had expected worse. (Forbes -- Business)
Amgen, J&J Anemia Treatments May Face U.S. Restrictions as Cancer Medicine Mar 7, 2008
The FDA urged doctors a year ago to use the lowest doses possible after dangers were seen in patients with kidney disease and head and neck cancer. An advisory panel is scheduled to discuss the new studies next week. (Bloomberg -- US)
Chemotherapy in Unresectable Head and Neck Cancer Mar 6, 2008
To the Editor: Radiotherapy alone in patients with advanced head and neck cancer is not the treatment of choice, even when cisplatin, fluorouracil, and docetaxel (TPF) are given ... 25 issue)1 report that TPF improved progression-free and overall survival in patients with unresectable head and neck cancer, but their results are disappointing as compared with chemoradiotherapy2,3 or radiotherapy with cetuximab ... 4 In the same issue, Posner et al. also report better results in patients with... (New England Journal of Medicine)
EU Commission Approves Updated Prescribing Information for Aranesp(R) Mar 5, 2008
ESA trials have shown an unexplained excess mortality in association with high target hemoglobin concentrations (greater than 12 g/dL), including (1) shortened time to tumor progression in patients with advanced head and neck cancer receiving radiation therapy; (2) shortened overall survival in patients with metastatic breast cancer receiving chemotherapy; (3) increased risk of death when administered to target a hemoglobin of 12g/dL (7. 5 mmol/l) in patients with active malignant disease... (BusinessWire)
PET/CT planning beneficial for head and neck cancer patients Mar 5, 2008
That study was the largest randomized trial of radiation therapy in locally advanced head and neck cancer. Disease free survival for the 42 study patients was 71 percent and 66. (EurekAlert!)
Drug For Anemic Cancer Patients Raises Risk Of Death, Study Shows Feb 29, 2008
Lai, a head and neck surgeon, saw a significant effect when he added an ESA called erythropoietin to head and neck cancer cells in tissue culture. "We saw a dramatic change," Lai said. (Science Daily)
Study Finds Variations in Doses of Radiation Therapy Feb 28, 2008
Twelve percent of the participants had brain cancer, 26 percent had head and neck cancer, while 62 percent had prostate cancer. The patients were treated at five different medical centers, each using different planning systems for the therapy. (MEDLINEplus)
Study finds increased risk of death from anemia drugs Feb 27, 2008
One option that analysts expect to be discussed at the meeting in March would be to bar the use of the drugs for specific types of cancer, like breast cancer and head and neck cancer. Another would be to delay treatment with the drugs until patients became more anemic than the current threshold, a change that would more closely match the Medicare reimbursement policy. (International Herald Tribune)
Genmab Agrees to Buy Minnesota Biotech Manufacturing Plant from ... Feb 22, 2008
Diseases targeted by its products include leukemias, lymphomas, rheumatoid arthritis, and head and neck cancer. Genmab's antibodies also have potential for treatment of many other diseases. (FOXBusiness)
HPV-Positive Head and Neck Cancers Fare Better Feb 14, 2008
TUESDAY, Feb. 12 (HealthDay News) -- Head and neck cancer patients whose tumors test positive for human papillomavirus (HPV) tend to survive longer and respond better to treatment than those who test negative, a new study says. HPV, a common virus with strains believed to be responsible for most cervical cancers, has recently been linked to the development of some head and neck cancers, particularly those of the upper throat, or oropharynx. (MEDLINEplus)
Vitamin A And Zinc Supplement May Help Protect Children From Malaria, Study Suggests Feb 8, 2008
3, 2007) Zinc sulfate, a supplement thought to be helpful in regaining the sense of taste for some head and neck cancer patients after radiation therapy, has been found to have no significant impact on. (Oct. (Science Daily)
Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data Jan 29, 2008
Proxinium(TM) is undergoing a global pivotal Phase 3 trial (the 'TARGET' trial) in approximately 300 patients with advanced head and neck cancer ... Proxinium(TM) Viventia's lead drug, Proxinium(TM), is a humanized antibody fragment conjugated to the cytotoxic protein Pseudomonas exotoxin A. The drug is in a global pivotal Phase 3 clinical trial (the 'TARGET' trial) in patients with advanced head and neck cancer ... Viventia's lead product, Proxinium(TM), is undergoing a global Phase 3 clinical... (Canada Newswire)
Exelixis CEO says planning pivotal trials and partnerships this year Jan 18, 2008
XL880 is a small-molecule MET inhibitor in Phase II for papillary renal cell carcinoma, gastric cancer and head and neck cancer. Scangos said more renal and gastric cancer data are expected at ASCO.. (FT.com -- Markets)
